SynthesisMedicine2020

Erlotinib plus tivantinib versus erlotinib alone in patients with previously treated stage IIIb/IV non-small-cell lung cancer: A meta-analysis based on randomized controlled trials.

Huan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.